Study finds HER2 irregularities in 14 different advanced solid tumors

[News]

The HER2 growth-factor gene is known to be over-active in breast and gastro-esophageal cancers. But now, irregularities in the genes's expression - among them mutations, amplifications, substitutions, and translocations - have been found in 14 different advanced solid tumors.

More... (http://www.news-medical.net/news/20130603/Study-finds-HER2-irregularities-in-14-different-advanced-solid-tumors.aspx)